Core Scientific, Inc. (CORZ) Financial Ratios
7 years of historical data (2019–2025) · Technology · Software - Infrastructure
EV/EBITDA
N/A
—
5yr avg: 39.22
30Y Low39.2·High39.2
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
↓
N/A
—
5yr avg: -227.1%
30Y Low-461%·High6%
Debt/EBITDA
↑
N/A
—
5yr avg: 8.06
30Y Low4.1·High13.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CORZ Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Core Scientific, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $9.3B | $4.6B | $3.6B | — | — | — | — | — |
| Enterprise Value | $10.0B | $5.4B | $4.0B | — | — | — | — | — |
| P/E Ratio → | -33.14 | — | — | — | — | — | — | — |
| P/S Ratio | 29.06 | 14.52 | 7.04 | — | — | — | — | — |
| P/B Ratio | — | — | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | 33.31 | 16.64 | 83.79 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CORZ EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 16.86 | 7.75 | — | — | — | — | — |
| EV / EBITDA | — | — | 39.22 | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
CORZ Profitability
Margins and return-on-capital ratios measuring operating efficiency
Core Scientific, Inc. earns an operating margin of -70.4%. Operating margins have compressed from 1.8% to -70.4% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 11.9% | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% | 17.7% |
| Operating Margin | -70.4% | -70.4% | -3.8% | 1.8% | -329.5% | 30.6% | -10.5% | -19.6% |
| Net Profit Margin | -90.5% | -90.5% | -257.5% | -49.1% | -335.2% | 8.7% | -20.2% | -20.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | -460.7% | 6.4% | -9.1% | -8.8% |
| ROA | -14.6% | -14.6% | -113.8% | -32.4% | -132.2% | 3.6% | -6.3% | -7.4% |
| ROIC | — | — | — | 3.1% | -191.2% | 11.3% | -3.1% | — |
| ROCE | -14.8% | -14.8% | -2.3% | 2.1% | -154.0% | 14.7% | -4.2% | -8.2% |
CORZ Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $749M ($1.1B total debt minus $311M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.61 | 0.30 | 0.06 |
| Debt / EBITDA | — | — | 11.89 | 8.21 | — | 4.09 | 13.10 | — |
| Net Debt / Equity | — | — | — | — | — | 0.52 | 0.24 | 0.01 |
| Net Debt / EBITDA | — | — | 3.60 | 7.73 | — | 3.50 | 10.28 | — |
| Debt / FCF | — | — | — | 16.65 | — | — | — | — |
| Interest Coverage | — | — | -34.45 | -1.85 | -21.34 | 2.42 | -1.75 | -49.73 |
CORZ Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.15x means Core Scientific, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.20x to 1.15x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | 1.02 | 0.57 |
| Quick Ratio | 1.15 | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | 1.02 | 0.57 |
| Cash Ratio | 0.40 | 0.40 | 6.21 | 0.10 | 0.09 | 0.37 | 0.12 | 0.34 |
| Asset Turnover | — | 0.14 | 0.32 | 0.71 | 0.79 | 0.22 | 0.27 | 0.37 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | 0.73 | 5.20 | 2.02 | 1.13 | 6.70 | 1.76 |
CORZ Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Core Scientific, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $318M | $256M | $380M | $341M | $233M | $380M | $380M |
Peer Comparison
Compare CORZ with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CORZYou | $9B | -33.1 | — | — | 11.9% | -70.4% | — | — | — |
 RIOT | $11B | -14.4 | — | — | -15.6% | -61.8% | -22.1% | -8.7% | — |
 MARA | $5B | -3.9 | — | — | -47.7% | -90.6% | -34.5% | -9.0% | — |
 CLSK | $4B | 15.4 | 7.8 | — | 41.6% | 41.6% | 18.5% | 10.3% | 1.2 |
 CIFR | $12B | -13.6 | — | — | 28.4% | -150.7% | -108.3% | -11.7% | — |
 BTBT | $707M | -7.0 | — | — | 21.4% | -49.8% | -12.1% | -5.8% | — |
 HUT | $14B | -58.1 | — | — | -614.6% | -2104.6% | -16.9% | -13.8% | — |
 IREN | $21B | 153.7 | 109.8 | — | 68.3% | 3.5% | 6.0% | 0.7% | 4.9 |
 WULF | $12B | -17.5 | — | — | 50.9% | -101.1% | -343.7% | -4.2% | — |
 BITF | $1B | -16.6 | 37.6 | — | -8.2% | -65.2% | -48.7% | -12.0% | — |
 MIGI | $5M | -0.3 | — | — | 43.6% | -50.0% | — | -62.9% | — |
| Technology Median | — | 29.0 | 16.7 | 19.2 | 48.8% | 0.2% | 1.6% | 2.7% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into CORZ consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
CORZ — Frequently Asked Questions
Quick answers to the most common questions about buying CORZ stock.
What is Core Scientific, Inc.'s P/E ratio?
Core Scientific, Inc.'s current P/E ratio is -33.1x. This places it at the 50th percentile of its historical range.
Is CORZ stock overvalued?
Based on historical data, Core Scientific, Inc. is trading at a P/E of -33.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Core Scientific, Inc.'s profit margins?
Core Scientific, Inc. has 11.9% gross margin and -70.4% operating margin.